Introduction and Clinical Aspects

Chapter
Part of the Essentials in Cytopathology book series (EICP, volume 8)

Abstract

The second edition of this book incorporates the recent terminology and reporting guidelines for thyroid fine needle aspirations (FNAs), the Bethesda System for Reporting Thyroid Cytopathology (BSRTC) that emerged from a multidisciplinary National Cancer Institute (NCI) Thyroid FNA State of the Science conference (2007). A major challenge in the application of FNA to the diagnosis of thyroid lesions has been the inconsistent use of terminology for reporting results of thyroid FNAs both within laboratories and between different institutions. Not only has this hindered the sharing of information between different institutions, but it has created difficulties for clinicians managing patients with thyroid disease. Throughout this second edition, we will use a simple algorithmic approach, which we have modified to incorporate the BSRTC, to explain how to evaluate thyroid FNAs.

Suggested Reading

  1. Agrawal S. Diagnostic accuracy and role of fine needle aspiration cytology in management of thyroid nodules. J Surg Oncol 1995;58:168.PubMedCrossRefGoogle Scholar
  2. Baloch ZW, LiVolsi VA. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008;36:425–437.PubMedCrossRefGoogle Scholar
  3. Bennedbaek FN, Hegedus L. Management of the solitary thyroid nodule: results of a North American Survey. J Endocrinol Metab 2000;85:2493.CrossRefGoogle Scholar
  4. Garcia-Mayor RV, Perez Mendez LF, Paramo C, et al. Fine needle aspiration biopsy of thyroid nodules: impact on clinical practice. J Endocrinol Invest 1997;20:482.Google Scholar
  5. Gharib H. Management of thyroid nodules: another look. Thyroid Today 1997;10:1.Google Scholar
  6. Gharib H, Goellner JR. Fine needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 1993;118:282.PubMedGoogle Scholar
  7. Pilotti S, Collini P, Manzari A, Marubini E, Rilke F. Poorly differentiated forms of papillary thyroid carcinoma: distinctive entities or morphological patterns? Semin Diagn Pathol 1995;12:249–255.PubMedGoogle Scholar
  8. Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer (Phila) 1983;52:1849–1855.CrossRefGoogle Scholar
  9. The American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:1–33.CrossRefGoogle Scholar
  10. Volante M, Collini P, Nikiforov YE, Sakamoto A, et al. Poorly differentiated thyroid carcinoma: the Tourin Proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 2007;31:1256–1264.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of PathologyThe Johns Hopkins Medical InstitutionsBaltimoreUSA
  2. 2.Department of Pathology Harvard Medical SchoolMassachusetts General HospitalBostonUSA

Personalised recommendations